Elucid

Elucid innovates and develops novel, AI-enabled and non-invasive solutions to deeply understand the biology of cardiovascular disease. As the first and only non-invasive image analysis software that employs CT angiography and histology-based patented computer algorithms, Elucid is establishing a new paradigm for heart attack and stroke prevention. SPRIG has supported Elucid with a range of marketing activities, spanning from commercial launch and strategy to downstream marketing efforts.